mine is used to treat heart failure, particularly after cardiac surgery in infants, but the mechanisms of action are unclear. We investigated differences in the effect of dopamine on L-type calcium current (ICa) between newborn (NB, 1-4 days) and adult (AD, 3-4 mo) rabbit ventricular myocytes. Myocytes were enzymatically dissociated from NB and AD rabbit hearts. I Ca was recorded by using the whole cell patch-clamp technique. mRNA levels of cardiac dopamine receptor type 1 (D1), type 2 (D2), and ␤-adrenergic receptors (␤-ARs) were measured by real-time RT-PCR. Dopamine (100 M) increased ICa more in NB (Emax 87 Ϯ 10%) than in AD ventricular cells (Emax 21 Ϯ 3%). Further investigation of this difference showed that mRNA levels of the D1 receptor were significantly higher in NB, and, with ␤-AR blockade, dopamine increased I Ca more in NB than AD cells. Additionally, SKF-38393 (selective D1 receptor agonist) significantly increased I Ca by 55 Ϯ 4% in NB (P Ͻ 0.05, n ϭ 4) and by 11 Ϯ 1% in AD (P Ͻ 0.05, n ϭ 6). Dopamine in the presence of SCH-23390 (D1 receptor antagonist) increased I Ca in NB cells by 67 Ϯ 5% and by 22 Ϯ 2% in AD cells, suggesting a role for ␤-AR stimulation. Selective blockade of ␤ 1-or ␤2-receptors (with block of D1 receptors) showed that the ␤-AR action of dopamine in the NB was largely mediated via ␤ 2-AR activation. Dopamine produces a larger increase in I Ca in NB cardiomyocytes compared with ADs. The mechanism of action is not only through ␤ 2-ARs but also due to higher expression of cardiac D1 receptor in NB. development; ␤-adrenergic receptors; ventricle DOPAMINE IS WIDELY USED TO treat heart failure, particularly after cardiac surgery in infants (3, 25, 48) . It is thought that dopamine acts directly on the heart via ␤-adrenergic receptors (␤-ARs) and indirectly due to effects on the vasculature via dopamine and ␣-adrenergic receptors (4, 10, 25, 34, 42) . A large body of evidence has demonstrated that the expression and function of ␤-ARs in heart is age dependent (1, 18, 50). Furthermore, there are developmental changes in ␤-AR modulation of the L-type calcium current (I Ca ) in newborn (NB) and adult (AD) rabbit ventricular cells, with isoproterenol producing a greater increase in I Ca in AD than in NB cells (38). Although there have been several studies on the effect of dopamine on I Ca in AD cardiomyocytes, there are no studies in NB cardiomyocytes. Habuchi et al. (20) reported no effect of low concentrations of dopamine on I Ca in cardiomyocytes of AD rat and rabbit heart. Zhao et al. (54) reported that dopamine increased I Ca via ␤-ARs in rat single atrial myocytes at low concentration and in ventricular myocytes at higher concentrations (20 -100 M). However, there are no reports that examine which ␤-AR subtypes are involved in the increase of I Ca in cardiomyocytes, particularly in NB cardiomyocytes.
DOPAMINE IS WIDELY USED TO treat heart failure, particularly after cardiac surgery in infants (3, 25, 48) . It is thought that dopamine acts directly on the heart via ␤-adrenergic receptors (␤-ARs) and indirectly due to effects on the vasculature via dopamine and ␣-adrenergic receptors (4, 10, 25, 34, 42) . A large body of evidence has demonstrated that the expression and function of ␤-ARs in heart is age dependent (1, 18, 50) . Furthermore, there are developmental changes in ␤-AR modulation of the L-type calcium current (I Ca ) in newborn (NB) and adult (AD) rabbit ventricular cells, with isoproterenol producing a greater increase in I Ca in AD than in NB cells (38) . Although there have been several studies on the effect of dopamine on I Ca in AD cardiomyocytes, there are no studies in NB cardiomyocytes. Habuchi et al. (20) reported no effect of low concentrations of dopamine on I Ca in cardiomyocytes of AD rat and rabbit heart. Zhao et al. (54) reported that dopamine increased I Ca via ␤-ARs in rat single atrial myocytes at low concentration and in ventricular myocytes at higher concentrations (20 -100 M). However, there are no reports that examine which ␤-AR subtypes are involved in the increase of I Ca in cardiomyocytes, particularly in NB cardiomyocytes.
Furthermore, it is not known if dopamine receptor type 1 (D1) and type 2 (D2) are involved in the mediation of the dopamine effect on I Ca in cardiac tissue. Molecular techniques have revealed that D1 and D2 receptors are present in rat heart tissue, human atrium and human ventricle (40, 41) . Other studies have shown that activation of D1 receptors leads to variable changes in I Ca in different types of neurons (2, 53) . It is unknown whether there is a developmental difference in the expression and action of dopamine receptors in cardiomyocytes.
Dopamine is frequently used for inotropic support in the postoperative period following surgery for congenital heart defects, but it is unclear whether the effectiveness of dopamine is due to direct effects on the myocardium. In this study we show that dopamine increases I Ca more in NB compared with AD rabbit ventricular myocytes, and we examine which receptor subtypes are responsible for this developmental difference in the action of dopamine. Furthermore, we measured mRNA levels of D1 and D2 receptors in NB compared with AD cardiomyocytes and the effect of dopamine on I Ca mediated by specific D1 and D2 receptor activation. We also compared the contribution of ␤ 1 -ARs, ␤ 2 -ARs, and D1 receptors to the increase of I Ca by dopamine in NB and AD cardiomyocytes by using specific receptor blockers.
MATERIALS AND METHODS
Cell preparation. New Zealand White AD (3-to 4-mo-old) and NB (1-to 4-day-old) rabbits of either sex were used in the experiments. Experimental procedures were conducted in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and approved by the Emory University Institutional Animal Care and Use Committee. Single ventricular cells were obtained from AD and NB hearts by enzymatic dissociation as we previously described (37) . In brief, AD rabbits were heparinized (500 IU/kg iv) and anesthetized with pentobarbital sodium (50 mg/kg iv). For NB rabbits, the same drugs were given intraperitoneally. The heart was rapidly removed via thoracotomy, and the aorta was cannulated. The dissected heart was mounted on a Langendorff apparatus and was perfused with oxygenated, Ca 2ϩ -free solution for 5 min at 36 -37°C, followed by the same solution containing 0.28 mg/ml collagenase (type I; Worthington Biochemical) and 0.03 mg/ml protease (type XIV; Sigma) for AD and 0.25 mg/ml collagenase (Yakult Honshu) and 0.05 mg/ml protease (type XIV; Sigma) for NB. The ventricle was cut into small pieces and triturated in Kraft-Brühe (KB) solution, and the suspension of isolated ventricular cells was stored at 4°C until use (within 8 h of dissociation). For transcript analysis, cells in KB solution were allowed to settle by gravity, the supernatant was replaced with fresh KB solution, and the cells were allowed to settle again (15) . The cell pellet was used for real-time RT-PCR.
Whole cell voltage-clamp recording. Experiments were carried out at room temperature (21-23°C). Voltage-clamp experiments were performed in the whole cell configuration with an Axopatch 200B patch-clamp amplifier (Axon Instruments, Molecular Devices) as previously described (47, 49) . Briefly, pipette resistance was 1.0 -2.0 M⍀ for AD cardiomyocytes and 3.5-4.5 M⍀ for NB cardiomyocytes. The liquid junction potential between the pipette and the bath solutions was corrected just before the seal formation. A tight seal (3-5 G⍀) was established in test solution, and I Ca was measured 5-8 min after the membrane was broken, when the recording was stable. ICa was elicited by depolarizing every 10 s from a holding potential of Ϫ45 mV to a test potential of ϩ10 mV for 360 ms. To obtain current-voltage relations, a series of test steps of 360-ms duration was applied with 10-mV increments (Ϫ40 to ϩ60 mV) from a holding potential of Ϫ45 mV. In our experimental conditions, K ϩ currents were eliminated with Cs ϩ and tetraethyl ammonium chloride in the pipette and Cs ϩ in the external test solution. Sodium current was inactivated by using a holding potential of Ϫ45 mV. Transcript analyses. Total RNA was extracted from AD and NB ventricular cell pellets by using the RNA isolation kit RNeasy (Qiagen) and were reverse transcribed by using a SuperScript III FirstStrand Synthesis kit with random hexamers (Invitrogen) according to the manufacturer's instructions. The quality of each RNA sample was confirmed by an Agilent 2100 bioanalyzer. The mRNA levels were measured by real-time RT-PCR (ABI 7500 PCR system). Specific primers were designed for each gene of interest on the basis of GenBank data and were followed by standard PCR reaction chemistry with the addition of the fluorescent DNA-binding dye, SYBR Green I (ABI). Forward and reverse primers for amplification were ATCTCTTGGTGGCTGTCTTGG and TACCTGTCCACGCTGA-TCACA for D1 receptor, TCAGATGCTTGCCATTGTTC and AACTCGATGTTGAAGGTGGTG for D2 receptor, AATGTGCTG-GTGATCGTGG and AAGAAGGAGCCGTACTCCCA for ␤ 1-AR, and TCTTCACGAACCAAGCCTATG and ATCCTGCTCCACCT-GGCTAA for ␤ 2-AR. The level of the 18S rRNA was determined by using the forward primer GGTGAAATTCTTGGACCGGC and reverse primer GACTTTGGTTTCCCGGAAGC. Product sizes for each primer pair were confirmed by gel electrophoresis. Real-time RT-PCR results for D1 receptor, D2 receptor, ␤ 1-AR, and ␤2-AR mRNA were normalized to results of 18S rRNA. Many studies have validated by using 18S rRNA for loading control under a number of experimental conditions (6, 26, 32, 43) . To compare how the mRNA levels of each gene changed with developmental age, results were normalized to the mean value from AD. Samples in duplicate were used.
Determination of D1 receptor protein levels by Western blot. Protein preparation and Western blot analysis were performed as we previously described (31, 47) . Briefly, on removal of the heart, ventricular tissue was separated and immediately frozen in liquid nitrogen. Frozen tissue was homogenized in lysis buffer [20 mM Tris ⅐ HCl, 1 mM EDTA pH 7.4, protease Inhibitor Cocktail (Roche Applied Science)]. The supernatant, after low-speed centrifugation (2 ϫ 10 min, 1,000 g), was then centrifuged at 100,000 g for 10 min to obtain membrane proteins. Protein concentration was measured by using the Bio-Rad protein assay, based on the method of Bradford (7).
Membrane proteins (30 g) were separated on a 12% SDS gel. Proteins from five NB and five AD rabbit hearts were loaded in alternating lanes. To determine levels of D1 receptor proteins, blots were incubated with rat monoclonal anti-D1 antibody (dilution 1:1,000; Sigma-Aldrich) overnight at 4°C, followed by a secondary antibody (goat anti-rat IgG-horseradish peroxidase, dilution 1:5,000; Santa Cruz Biotechnology) and detection by an enhanced chemiluminescence assay (Pierce ECL Western Blotting Substrate; Thermo Scientific). After exposure to X-ray film, the bands were quantified by densitometry with ImageJ (NIH, Bethesda, MD). The blot was stripped by using Restore Western Blot Stripping buffer (Thermo Scientific) and then incubated with mouse anti-GAPDH (IgG, dilution 1:150; Chemicon International) for 3 h at room temperature followed by incubation with a secondary antibody (goat anti-mouse IgGhorseradish peroxidase; Santa Cruz Biotechnology).
Statistical analysis. Statistical significance was determined by Student's t-test for paired or unpaired data. Values of P Ͻ 0.05 were regarded as significant. Data are presented as means Ϯ SE.
RESULTS
Greater effect of dopamine on I Ca in NB compared with AD ventricular myocytes. To determine whether there was an age-dependent difference in the effect of dopamine on I Ca , we tested the effect of increasing concentrations of dopamine on I Ca recorded from AD and NB rabbit ventricular cells. Examples of the time course of the current amplitude (Fig. 1, A and B, top) and current traces in control and in response to 100 M dopamine (Fig. 1, A and B, bottom) are shown in Fig. 1 for AD (A) and for NB (B) cells. The mean basal current for the AD was 6.0 Ϯ 0.5 pA/pF, which increased to 7.0 Ϯ 0.7 pA/pF (n ϭ 7, P Ͻ 0.05) with dopamine (100 M). Under the same conditions, the basal current was 2.6 Ϯ 0.2 pA/pF in the NB, which nearly doubled with dopamine to 4.9 Ϯ 0.4 pA/pF (n ϭ 6, P Ͻ 0.05). The larger basal current in the AD is consistent with our previous studies (35, 39) . The concentration-dependent effects of dopamine are summarized in Fig. 1C as doseresponse curves for AD and NB rabbit ventricular cells. The maximal effect of dopamine (E max ) and the concentration required for half-maximal stimulation (EC 50 ) were 21 Ϯ 3% and 44 Ϯ 6 M, respectively, for AD cells and 87 Ϯ 10% and 26 Ϯ 7 M, respectively, for NB cells. Dopamine was significantly more effective in NB cells for concentrations Ͼ10 M. We examined the current-voltage relationships for AD cells (n ϭ 7) and NB cells (n ϭ 6) before treatment (control) and after treatment with 100 M dopamine, and these results are shown in Fig. 1D . The voltage dependence of I Ca was not changed by the application of dopamine for either the AD or NB cells.
Determination of mRNA levels of D1, D2, ␤ 1 -, and ␤ 2 -receptors in NB and AD myocytes and protein levels of D1 receptors. The direct effects of dopamine on the myocardium are thought to be mediated through ␤-ARs, although dopamine receptors have been shown to be present in cardiac tissue (40, 41) . To begin to determine whether the differential effect of dopamine on I Ca in AD and NB cells is due to activation of different receptor subtypes, we measured the relative expression of D1 receptor, D2 receptor, ␤ 1 -AR, and ␤ 2 -AR mRNA in AD and NB ventricular cells ( Fig. 2A) . Results are normalized to the mean determined from AD cells for ease of comparison. The level of D1 receptor mRNA is sevenfold larger in the NB rabbit myocytes compared with the AD (n ϭ 8 rabbits for each age; P Ͻ 0.05), whereas the level of the D2 receptor is smaller in the NB compared with the AD (n ϭ 8 rabbits for each age; Fig. 2 . Developmental changes in levels of dopamine type 1 and type 2 receptors (D1 and D2) and ␤1-and ␤2-adrenergic receptors (␤1-AR and ␤2-AR). A: mRNA levels measured by real-time RT-PCR, normalized to 18S rRNA, and expressed compared with mean level in AD. D1 receptor and ␤2-AR mRNA levels were upregulated in NB ventricular myocytes (n ϭ 8 rabbits, gray bars) compared with AD ventricular myocytes (n ϭ 8 rabbits, open bars), whereas D2 and ␤1-AR levels were downregulated in NB. B: Western blot probed with D1 receptor antibody (top) and GAPDH antibody (bottom) for NB and AD ventricular homogenates (alternating lanes, n ϭ 5 rabbits for each age). Right: densitometric analysis of D1 receptor protein normalized to GAPDH showing much lower levels in AD vs. NB. *P Ͻ 0.05. P Ͻ 0.05). The ␤ 1 -and ␤ 2 -AR mRNA also show age-dependent changes, with the NB cells having less ␤ 1 -AR mRNA and more ␤ 2 -AR mRNA than the AD cells (n ϭ 8 rabbits for each age; P Ͻ 0.05).
We confirmed that the mRNA levels of the D1 receptor corresponded to a change in the protein levels by Western blot analysis. Figure 2B shows a section of a blot of protein from ventricular tissue from NB and AD rabbits in alternating lanes, probed for D1 receptor and GAPDH. D1 receptor protein level for AD (n ϭ 5 hearts) and NB (n ϭ 5 hearts) was normalized to GAPDH. Note that the protein levels for D1 receptor are 6.7-fold higher in the NB compared with the AD, consistent with the mRNA levels of the D1 receptor.
Greater increase in I Ca in NB than in AD myocytes via D1 receptor activation. The higher level of D1 receptor mRNA and protein in NB compared with AD suggests that the greater response to dopamine in the NB may be through D1 receptor activation. Thus we compared the effects of 1 M SKF, a potent D1 receptor agonist, on I Ca from NB compared with AD ventricular cells (Fig. 3) . Examples of the time course of current amplitude (Fig. 3, A and B , top) and current traces (Fig.  3, A and B, bottom) are shown for an AD (Fig. 3A) and NB (Fig. 3B) cell. The effect of SKF was greater in the NB cell. In  Fig, 3C , mean current density in control and SKF for AD and NB are shown. There is a significant positive effect of SKF in both AD and NB cells, but note that the percent increase of I Ca by SKF is significantly larger in NB cells than in AD cells (Fig. 3D ).
An alternate method to examine the role of D1 receptors is to apply dopamine in the presence of ␤ 1 -and ␤ 2 -AR blockade. These results are shown in Fig. 4 . When we pretreated the cells with 1 M propranolol (␤-AR blockade), the effect of dopamine was nearly abolished in the AD (Fig. 4 , A and C, no significant increase), whereas a small but significant effect was still present in the NB cells (Fig. 4, B and C) . The percent increase in I Ca in NB cells with dopamine in the presence of ␤-AR blockade was significantly larger than the increase in the AD cells as shown in Fig. 4D . To exclude the possibility that dopamine is acting through D2 receptors, we examined the effects of a specific D2 agonist (TNPA, 1 M) on I Ca in NB and AD cells. TNPA did not alter I Ca in either NB (Ϫ4 Ϯ 2%, n ϭ 7) or AD (3 Ϯ 2%, n ϭ 7) cells.
Effect of dopamine on I Ca other than via D1 activation. To determine whether blockade of the D1 receptor altered the effect of dopamine in NB and AD cells, we applied dopamine after pretreatment with 10 M SCH (a selective D1 receptor antagonist), and these results are shown in Fig. 5 . Figure 5A representative trace from a NB cell. Figure 5C is a summary of the results, which shows the mean effects on AD and NB cells of dopamine applied after pretreatment with SCH, with a small, significantly positive effect on AD cells (from 4.9 Ϯ 0.2 pA/pF to 5.9 Ϯ 0.1 pA/pF, n ϭ 7, P Ͻ 0.05) and a larger, significantly positive effect for NB cells (from 2.4 Ϯ 0.3 pA/pF to 3.9 Ϯ 0.6 pA/pF, n ϭ 6, P Ͻ 0.05). Figure 5D shows the relative effect on AD vs. NB cells of dopamine after pretreatment with SCH, with a significantly larger effect on NB cells (67 Ϯ 5% increase). In the NB, the effect of dopamine in the presence of D1 receptor blockade is smaller but not significantly different (P ϭ 0.086) from the percent increase due to 100 M dopamine alone (87%, Fig. 1C ). These results suggest that the effectiveness of dopamine in the NB is not solely due to the greater amount of D1 receptor and that this differential effect is partially mediated through ␤-AR activation.
Greater increase of I Ca in NB vs. AD myocytes is due to ␤ 2 -AR activation. To determine whether the differential action of dopamine via ␤-ARs contributes to the greater effect of dopamine in the NB, we applied dopamine while blocking combinations of ␤ 1 -ARs (blocked by 300 nM CGP), ␤ 2 -ARs (blocked by 50 nM ICI), and D1 (blocked by 10 M SCH). Figure 6 summarizes the results for AD and NB cells with combinations of these receptor blockers. Figure 6A shows the values of I Ca obtained before and after application of 100 M dopamine, and Figure 6B shows the percent increase in I Ca under the same conditions. The left-most group shows the results for application of 100 M dopamine while blocking ␤ 1 and D1 receptors (with CGP and SCH). Under these conditions, dopamine increases I Ca significantly for both the AD and NB cells, but the increase was much larger in the NB. In the middle group we blocked ␤ 2 and D1 receptors (with ICI and SCH). Dopamine increased I Ca significantly in both the AD and the NB, and the percent increase was ϳ20% and not different between the two ages. To confirm that the action of dopamine was via ␤-ARs and D1 receptors and to further exclude activation of D2 receptors, we blocked ␤ 1 , ␤ 2 , and D1 receptors with 1 M propranolol and 10 M SCH. There was no increase in I Ca in response to dopamine in either the AD or NB cells (far right group in Fig. 6 ). In summary, the greatest effect of dopamine was in the NB via ␤ 2 -receptor activation (56 Ϯ 8% increase). This was significantly smaller than the effect of dopamine alone (87%, P ϭ 0.026, Fig. 1C ).
DISCUSSION
In this study, we show for the first time that dopamine is more effective in increasing I Ca in NB rabbit ventricular myocytes compared with AD myocytes. Using specific receptor agonists and antagonists, we show that the greater effectiveness of dopamine in the NB is due in part to activation of D1 receptors and also due to activation of ␤-ARs, in particular ␤ 2 -ARs. These findings correlate with higher D1 receptor and ␤ 2 -AR mRNA levels and higher D1 receptor protein levels in NB compared with AD.
The myocardial effects of dopamine are primarily thought to occur via ␤-AR stimulation (34, 46) . In isolated adult rat ventricular myocytes, Zhao et al. (54) showed that dopamine increased I Ca and that this effect was blocked by propranolol, suggesting that the effect of dopamine was mediated by ␤-ARs. These results are similar to what we have now shown in AD rabbit ventricular myocytes (Fig. 4) . In contrast, we show that propranolol does not completely block the effect of dopamine in NB rabbit ventricular cells, suggesting that there is an additional mode of action for dopamine in the NB, possibly through dopamine receptors. The presence of D1 and D2 receptors has been reported in rat and human cardiac tissue (36, 40, 44) . Competitive PCR analysis showed that the D1 A receptor mRNA level was significantly higher at 4 wk than at 8 and 20 wk of age in rat ventricular tissue (28) . Similar studies in the newborn have not been shown. Thus we examined the mRNA levels of D1 and D2 receptors and found that NB rabbit ventricle had higher levels of D1 receptor mRNA and protein and lower levels of D2 receptor mRNA than AD (see Fig. 2 ). Furthermore, functional greater expression of D1 receptors in NB was demonstrated by specific stimulation with SKF, which increased I Ca more in NB compared with AD cells. Activation of D2 receptors (TNPA) produced no significant change of I Ca in either NB or AD cells.
Specific activation of D1 receptors in NB increased I Ca by 55% but had a small effect on AD cells. This may suggest that most of the 87% increase in I Ca by dopamine in NB cells (Fig.  1) can be accounted for by direct stimulation of D1 receptors. However, when we pretreated the cells with propranolol (to block ␤ 1 -and ␤ 2 -ARs) followed by the application of dopamine to determine the D1 receptor contribution, we found an increase of only 18% in I Ca . This may be attributed to the lower binding affinity to the D1 receptor for dopamine than for SKF, as was shown in sheep ventromedial hypothalamic nucleus (13) . In addition, when we blocked D1 receptors with SCH, the amount of increase of I Ca in NB cells with dopamine was 67%. Together these results suggested a more prominent role of ␤-receptor activation in the effects of dopamine on I Ca in NB cells.
To explore the role of subtypes of ␤-ARs, we showed significantly less ␤ 1 -AR mRNA and significantly more ␤ 2 -AR mRNA for NB cells compared with AD cells. The expression and function of ␤-ARs have been shown to change with age (12, 50) . The number of ␤-ARs (density) in the heart increases during development from fetal level to the neonatal/young level and then decreases to AD level in different species of animals [rat (22) , mouse (11) , dog (45) , and rabbit (17)]. Effects of the activation of both ␤ 1 -ARs and ␤ 2 -ARs were progressively decreased in ventricular myocytes of 2-, 8-, and 24-mo-old rat myocytes (50) . Kuznetsov et al. (24) showed that the percent of ␤ 2 -ARs in freshly dissociated adult rat ventricular cells was not different from cultured neonatal rat cells, although it has been shown that culture alters ␤-ARs expression (27) . To our knowledge, it has not been definitively shown that the ratio of ␤ 1 -to ␤ 2 -ARs does not change with age when acutely isolated ventricular cells from NB and AD rabbit heart are used. In the AD rabbit, the percentage of ␤ 1 -ARs in ventricle has been reported as 92% (8), 85.5% (19) , and 77% (29) . In this study, we have shown higher levels of ␤ 2 -AR mRNA in NB vs. AD rabbit ventricular cells. Further experiments on ␤-AR protein subtype expression in the developing rabbit heart are required.
Because dopamine is thought to act via ␤-ARs in the heart (34, 46), our results showing that dopamine is more effective in NB than in AD is paradoxical in light of studies showing that isoproterenol (a strong ␤-AR agonist) increases I Ca to a larger degree in AD rabbit ventricular cells compared with NB cells (38) . In adult human ventricle, dopamine was less effective than isoproterenol and norepinephrine in augmenting the contraction (9) . Furthermore, in human adult atria, Deighton et al. (14) showed that the effect of dopamine was less than that of isoproterenol and that dopamine acted primarily via ␤ 1 -ARs. In the present study, we show that in the AD rabbit, the effect of dopamine on I Ca is smaller than that of isoproterenol and that dopamine acts primarily via ␤ 1 -ARs. In contrast, in the NB rabbit, we show that dopamine acts via ␤ 1 -and ␤ 2 -ARs as well as D1 receptors and that dopamine is more effective than in the AD. Furthermore, dopamine is slightly less effective at increasing I Ca (87%) in the NB compared with the effect of isoproterenol (111%) (38) . Although dopamine and isoproterenol are both ␤-AR agonists, isoproterenol is a full ␤ 2 -AR agonist, whereas dopamine is a partial ␤ 2 -AR agonist (51) .
In this study, we have demonstrated that the difference between the effect of dopamine in NB and AD rabbits is due to a greater effect of dopamine via ␤ 2 -AR and D1 receptors in the NB compared with the AD. In other cell systems, dopamine has been shown to act via ␤-ARs. Dopamine acts via ␤ 1 -and ␤ 2 -ARs (each partially) in astroglial cells (16) and via D1 receptors as well as ␤ 1 -and ␤ 2 -ARs in glioma cells (30) . Differential effects of ␤ 1 -vs. ␤ 2 -AR activation have also been shown to vary with developmental age. Kuznetsov et al. (24) found that zinterol (specific agonist of ␤ 2 -ARs) evoked a substantial increase in cAMP accumulation in rat neonatal cardiomyocytes but only a minor increase in AD cardiomyocytes. In addition, they showed that ␤ 2 -receptor activation contributed to the positive inotropic response, increasing the amplitude and hastening the kinetics of the twitch in NB but not AD myocytes, and that activation of ␤ 2 -AR receptors produced a greater increase in I Ca in NB compared with AD myocytes. Furthermore, Molenaar et al. (33) showed that both ␤ 1 -and ␤ 2 -AR agonists were equally effective in increasing the contraction in infant human ventricle. Our results that dopamine acts in part via ␤ 2 -AR stimulation are consistent with recent work from Collis et al. (12) that shows that ␤ 2 -AR stimulation is much more effective in increasing I Ca in the NB rabbit ventricular cells compared with AD. Furthermore, they showed that the effect of isoproterenol on I Ca in the AD was due to stimulation of ␤ 1 -ARs only, whereas the isoproterenol effect in the NB was due to stimulation of both ␤ 1 -and ␤ 2 -ARs. Recently, Huang et al. (21) has shown a switch in splice variants of the ␣ 1C -subunit of the calcium channel from the IVS3A to the IVS3B variant with development in the rabbit. We have confirmed these studies by RT-PCR in our laboratory (data not shown). They speculate that the different splice variants may determine the localization of the calcium channels because the IVS section of the ␣ 1C -subunit has a possible caveolin binding site. Bajelipelli et al. (5) recently showed that ␤ 2 -ARs colocalize with caveolin-3, Ca v 1.2, and G s and that disruption of caveoli abolishes the stimulatory effect of a ␤ 2 -AR agonist on I Ca . Furthermore, the D1 receptor has been shown to localize with caveolin-1 in brain (23) and caveolin-2 in kidney (52); thus it may localize with caveolin-3 in heart. It is possible that the different splice variants of the ␣ 1C -channel may help localize the receptors (␤ 2 -ARs or D1 receptors) with the calcium channel and thus result in a greater effect via ␤ 2 -ARs or D1 receptors in the NB.
We have shown that dopamine is more effective in increasing I Ca in isolated rabbit NB cardiomyocytes compared with AD myocytes. Furthermore, we have shown that the greater effect of dopamine in the NB is due to activation of both D1 receptors and ␤ 2 -ARs. Dopamine and specific stimulation of D1 receptors by SKF both caused a larger increase in I Ca in NB compared with AD cells, but SKF produced a larger effect compared with dopamine acting via the D1 receptors (by blocking ␤-ARs). This study also suggests that the ␤-AR action of dopamine in NB cells is substantially mediated by activation of ␤ 2 -ARs. Together, these results suggest that specific activation of D1 receptors and of ␤ 2 -ARs may be more effective in increasing inotropy in the NB compared with the AD and thus may be useful therapeutic targets for the pediatric cardiac patient.
